Inhibition of Midkine Augments Osteoporotic Fracture Healing

Melanie Haffner-Luntzer1, Julia Kemmler1, Verena Heidler1

  • 1Institute of Orthopedic Research and Biomechanics, University Medical Center Ulm, Ulm, Germany.

Plos One
|July 14, 2016
PubMed

Insights

Inhibiting midkine (Mdk) with an antibody improved bone healing in osteoporotic mice. This therapy enhanced bone formation and increased bone mass, offering potential for treating osteoporosis and related fracture complications.

Area of Science:

  • Skeletal Biology
  • Bone Metabolism
  • Regenerative Medicine

Background:

  • Midkine (Mdk) negatively regulates osteoblast activity and bone formation.
  • Mdk deficiency protects against ovariectomy (OVX)-induced bone loss, suggesting a role in postmenopausal osteoporosis.
  • Mdk impairs bone regeneration during fracture healing.

Purpose of the Study:

  • To investigate if Mdk inhibition using an Mdk-antibody (Mdk-Ab) improves compromised bone healing in osteoporotic OVX-mice.
  • To assess the therapeutic potential of Mdk antagonism for osteoporosis and associated fracture complications.

Main Methods:

  • Utilized a standardized femur osteotomy model in OVX-mice.
  • Administered systemic Mdk-Ab treatment.
  • Measured Mdk serum levels and analyzed bone formation in the fracture callus.
  • Assessed beta-catenin signaling pathway activity.
  • Evaluated trabecular bone mass.

Main Results:

  • Mdk serum levels increased significantly after fracture, with a greater elevation in OVX-mice.
  • Mdk-Ab treatment significantly improved bone healing in osteoporotic mice by enhancing callus bone formation.
  • Mdk-Ab treatment reversed the OVX-induced reduction in beta-catenin signaling in the bony callus.
  • Mdk-Ab injection increased overall trabecular bone mass in OVX-mice.

Conclusions:

  • Antagonizing Mdk with an Mdk-Ab is a promising therapeutic strategy for improving bone healing in osteoporosis.
  • Mdk inhibition can restore osteoanabolic signaling and increase bone mass in osteoporotic conditions.
  • Targeting Mdk may effectively treat osteoporosis and complications of osteoporotic fracture healing.